JESSE I TREU Insider Trading Transactions

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for JESSE I TREU.

Your email is safe with us.
The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of JESSE I TREU. JESSE I TREU is 10% Owner in SENOMYX INC ($SNMX) and 10% Owner in INTRALASE CORP ($ILSE) and 10% Owner in Paratek Pharmaceuticals, Inc. ($PRTK) and 10% Owner in SANTARUS INC ($SNTS) and 10% Owner in NUVASIVE INC ($NUVA) and 10% Owner in ALIMERA SCIENCES INC ($ALIM) and 10% Owner in Ocera Therapeutics, Inc. ($TZYM) and Director in Northstar Neuroscience, Inc. ($NSTR) and 10% Owner in ACHILLION PHARMACEUTICALS INC ($ACHN) and 10% Owner in Achaogen Inc ($AKAO) and Director in Tobira Therapeutics, Inc. ($TBRA) and 10% Owner in CADENCE PHARMACEUTICALS INC ($CADX) and Director in SENORX INC ($SENO) and Director in Pernix Sleep, Inc. ($SOMX) and Director in CoLucid Pharmaceuticals, Inc. ($CLCD) and 10% Owner in INTERCELL USA, INC. ($IOMI) and Director in Aldeyra Therapeutics, Inc. ($ALDX) and 10% Owner in Vanda Pharmaceuticals Inc. ($VNDA) and 10% Owner in Volcano Corp ($VOLC) and 10% Owner in ZOGENIX, INC. ($ZGNX) and Director in VERACYTE, INC. ($VCYT) and 10% Owner in Orexigen Therapeutics, Inc. ($OREX) and 10% Owner in Dicerna Pharmaceuticals Inc ($DRNA) and 10% Owner in Evoke Pharma Inc ($EVOK) and 10% Owner in Esperion Therapeutics, Inc. ($ESPR) and Director in TANDEM DIABETES CARE INC ($TNDM) and 10% Owner in Clovis Oncology, Inc. ($CLVS) and 10% Owner in REVA Medical, Inc. ($RVA) and 10% Owner in Durata Therapeutics, Inc. ($DRTX).

Latest Insider Trading Transactions of JESSE I TREU

	1 Week	2 Weeks	1 Month	3 Months	6 Months	1 Year	2 Years
No. of Purchases	0	0	0	0	0	0	0
Value of Purchases ($)	0	0	0	0	0	0	0
No. of Sales	0	0	0	0	0	0	0
Value of Sales ($)	0	0	0	0	0	0	0

Sentiment: All, AKAO, ACHN, ALDX, ALIM, CADX, CLVS, CLCD, DRNA, DRTX, ESPR, EVOK, IOMI, ILSE, NSTR, NUVA, TZYM, OREX, PRTK, SOMX, RVA, SNTS, SNMX, SENO, TNDM, TBRA, VNDA, VCYT, VOLC, ZGNX

Page: 1 2 3 4 4 next >

Date	Ticker	Company	Owner	Relationship	Transaction	Code	Cost ($)	Shares	Transaction Value ($)	Total Shares	% Holdings
Jun 11 2020	ALDX	Aldeyra Therapeuti ...	TREU JESSE I	Director	Option Exercise	A	5.02	2,311	11,601	2,311
Jun 11 2020	ALDX	Aldeyra Therapeuti ...	TREU JESSE I	Director	Option Exercise	A	5.02	2,465	12,374	2,465
Jun 11 2020	ALDX	Aldeyra Therapeuti ...	TREU JESSE I	Director	Option Exercise	A	5.02	26,503	133,045	26,503
Jun 06 2019	ALDX	Aldeyra Therapeuti ...	TREU JESSE I	Director	Option Exercise	A	7.06	1,653	11,670	1,653
Jun 06 2019	ALDX	Aldeyra Therapeuti ...	TREU JESSE I	Director	Option Exercise	A	7.06	1,763	12,447	1,763
Jun 06 2019	ALDX	Aldeyra Therapeuti ...	TREU JESSE I	Director	Option Exercise	A	7.06	18,951	133,794	18,951
Jun 06 2019	ALDX	Aldeyra Therapeuti ...	TREU JESSE I	Director	Option Exercise	A	7.06	1,653	11,670	1,653
Jun 06 2019	ALDX	Aldeyra Therapeuti ...	TREU JESSE I	Director	Option Exercise	A	7.06	1,763	12,447	1,763
Jun 06 2019	ALDX	Aldeyra Therapeuti ...	TREU JESSE I	Director	Option Exercise	A	7.06	18,951	133,794	18,951
Mar 28 2019	ALDX	Aldeyra Therapeuti ...	TREU JESSE I	Director	Sell	S	10.01	445	4,454	8,763	9.2 K to 8.8 K (-4.83 %)
Mar 28 2019	ALDX	Aldeyra Therapeuti ...	TREU JESSE I	Director	Sell	S	10.01	96,298	963,943	1,877,091	2 M to 1.9 M (-4.88 %)
Aug 02 2018	VCYT	VERACYTE, INC.	TREU JESSE I	Director	Sell	S	10.85	888	9,635	16,804	17.7 K to 16.8 K (-5.02 %)
Aug 02 2018	VCYT	VERACYTE, INC.	TREU JESSE I	Director	Sell	S	10.85	119,112	1,292,365	2,266,994	2.4 M to 2.3 M (-4.99 %)
Aug 02 2018	VCYT	VERACYTE, INC.	TREU JESSE I	Director	Sell	S	10.82	2,812	30,426	17,692	20.5 K to 17.7 K (-13.71 %)
Aug 02 2018	VCYT	VERACYTE, INC.	TREU JESSE I	Director	Sell	S	10.82	377,188	4,081,174	2,386,106	2.8 M to 2.4 M (-13.65 %)
Jun 11 2018	ALDX	Aldeyra Therapeuti ...	TREU JESSE I	Director	Option Exercise	A	8.35	1,444	12,057	1,444
Jun 11 2018	ALDX	Aldeyra Therapeuti ...	TREU JESSE I	Director	Option Exercise	A	8.35	1,354	11,306	1,354
Jun 11 2018	ALDX	Aldeyra Therapeuti ...	TREU JESSE I	Director	Option Exercise	A	8.35	15,526	129,642	15,526
Jun 08 2018	VCYT	VERACYTE, INC.	TREU JESSE I	Director	Option Exercise	A	7.60	10,000	76,000	10,000
Jun 12 2017	ALDX	Aldeyra Therapeuti ...	TREU JESSE I	Director	Option Exercise	A	5.15	2,370	12,206	2,370
Jun 12 2017	ALDX	Aldeyra Therapeuti ...	TREU JESSE I	Director	Option Exercise	A	5.15	2,222	11,443	2,222
Jun 12 2017	ALDX	Aldeyra Therapeuti ...	TREU JESSE I	Director	Option Exercise	A	5.15	17,776	91,546	17,776
Jun 09 2017	VCYT	VERACYTE, INC.	TREU JESSE I	Director	Option Exercise	A	7.94	10,000	79,400	10,000
May 18 2017	VCYT	VERACYTE, INC.	TREU JESSE I	Director	Sell	S	8.08	2,226	17,986	20,504	22.7 K to 20.5 K (-9.79 %)
May 18 2017	VCYT	VERACYTE, INC.	TREU JESSE I	Director	Buy	J	0.00	1,641	0	1,641	0 to 1.6 K
May 18 2017	VCYT	VERACYTE, INC.	TREU JESSE I	Director	Buy	J	0.00	1,642	0	1,642	0 to 1.6 K
May 18 2017	VCYT	VERACYTE, INC.	TREU JESSE I	Director	Sell	J	0.00	25,245	0	0	25.2 K to 0 (-100.00 %)
Nov 17 2016	TNDM	TANDEM DIABETES CA ...	TREU JESSE I	Director	Option Exercise	A	1.90	17,000	32,300	17,000
Jun 22 2016	VCYT	VERACYTE, INC.	TREU JESSE I	Director	Option Exercise	A	5.28	10,000	52,800	10,000
Jun 13 2016	ALDX	Aldeyra Therapeuti ...	TREU JESSE I	Director	Option Exercise	A	5.97	6,083	36,316	6,083
Nov 17 2015	TNDM	TANDEM DIABETES CA ...	TREU JESSE I	Director	Option Exercise	A	10.13	17,000	172,210	17,000
Jun 10 2015	ALDX	Aldeyra Therapeuti ...	TREU JESSE I	Director	Option Exercise	A	7.74	6,083	47,082	6,083
May 20 2015	VCYT	VERACYTE, INC.	TREU JESSE I	Director	Option Exercise	A	10.41	10,000	104,100	10,000
May 07 2015	CLCD	CoLucid Pharmaceut ...	TREU JESSE I	Director	Option Exercise	A	10.00	5,954	59,540	5,954
Jan 05 2015	TBRA	Tobira Therapeutic ...	TREU JESSE I	Director	Option Exercise	A	0.91	159,261	144,928	159,261
Nov 19 2014	TNDM	TANDEM DIABETES CA ...	TREU JESSE I	Director	Option Exercise	A	14.53	17,000	247,010	17,000
May 21 2014	VCYT	VERACYTE, INC.	TREU JESSE I	Director	Option Exercise	A	13.19	10,000	131,900	10,000
May 07 2014	ALDX	Aldeyra Therapeuti ...	TREU JESSE I	Director	Option Exercise	A	8.00	12,166	97,328	12,166
Jan 03 2014	TBRA	Tobira Therapeutic ...	TREU JESSE I	Director	Option Exercise	A	4.77	9,640	45,983	9,640
Feb 04 2014	DRNA	Dicerna Pharmaceut ...	TREU JESSE I	10% Owner	Option Exercise	C	7.00	156	1,092	156
Feb 04 2014	DRNA	Dicerna Pharmaceut ...	TREU JESSE I	10% Owner	Option Exercise	C	7.00	156	1,092	0
Feb 04 2014	DRNA	Dicerna Pharmaceut ...	TREU JESSE I	10% Owner	Option Exercise	C	0.00	9,469	0	0
Feb 04 2014	DRNA	Dicerna Pharmaceut ...	TREU JESSE I	10% Owner	Option Exercise	C	0.00	3,535	0	0
Feb 04 2014	DRNA	Dicerna Pharmaceut ...	TREU JESSE I	10% Owner	Option Exercise	C	7.00	21,041	147,287	21,041
Feb 04 2014	DRNA	Dicerna Pharmaceut ...	TREU JESSE I	10% Owner	Option Exercise	C	7.00	21,041	147,287	0
Feb 04 2014	DRNA	Dicerna Pharmaceut ...	TREU JESSE I	10% Owner	Option Exercise	C	0.00	1,276,243	0	0
Feb 04 2014	DRNA	Dicerna Pharmaceut ...	TREU JESSE I	10% Owner	Option Exercise	C	0.00	476,464	0	0
Feb 04 2014	DRNA	Dicerna Pharmaceut ...	TREU JESSE I	10% Owner	Buy	C	0.00	13,004	0	13,004	0 to 13 K
Feb 04 2014	DRNA	Dicerna Pharmaceut ...	TREU JESSE I	10% Owner	Buy	C	0.00	1,752,707	0	1,752,707	0 to 1.8 M
Mar 21 2014	CADX	CADENCE PHARMACEUT ...	TREU JESSE I	10% Owner	Sell	D	14.00	27,500	385,000	0	27.5 K to 0 (-100.00 %)
Mar 21 2014	CADX	CADENCE PHARMACEUT ...	TREU JESSE I	10% Owner	Sell	D	14.00	78,369	1,097,166	0	78.4 K to 0 (-100.00 %)
Mar 21 2014	CADX	CADENCE PHARMACEUT ...	TREU JESSE I	10% Owner	Sell	D	14.00	7,313,241	102,385,374	0	7.3 M to 0 (-100.00 %)
Mar 21 2014	CADX	CADENCE PHARMACEUT ...	TREU JESSE I	10% Owner	Sell	D	14.00	50,743	710,402	0	50.7 K to 0 (-100.00 %)
Mar 21 2014	CADX	CADENCE PHARMACEUT ...	TREU JESSE I	10% Owner	Sell	D	14.00	2,972,678	41,617,492	0	3 M to 0 (-100.00 %)
Mar 17 2014	AKAO	Achaogen Inc	TREU JESSE I	10% Owner	Option Exercise	C	0.00	7,430	0	0
Mar 17 2014	AKAO	Achaogen Inc	TREU JESSE I	10% Owner	Option Exercise	C	0.00	15,799	0	0
Mar 17 2014	AKAO	Achaogen Inc	TREU JESSE I	10% Owner	Option Exercise	C	0.00	10,661	0	0
Mar 17 2014	AKAO	Achaogen Inc	TREU JESSE I	10% Owner	Option Exercise	C	0.00	435,663	0	0
Mar 17 2014	AKAO	Achaogen Inc	TREU JESSE I	10% Owner	Option Exercise	C	0.00	926,321	0	0
Mar 17 2014	AKAO	Achaogen Inc	TREU JESSE I	10% Owner	Option Exercise	C	0.00	625,065	0	0
Mar 17 2014	AKAO	Achaogen Inc	TREU JESSE I	10% Owner	Buy	C	0.00	33,890	0	33,890	0 to 33.9 K
Mar 17 2014	AKAO	Achaogen Inc	TREU JESSE I	10% Owner	Buy	C	0.00	1,987,049	0	1,987,049	0 to 2 M
Nov 04 2013	VCYT	VERACYTE, INC.	TREU JESSE I	Director	Option Exercise	C	0.00	5,053	0	0
Nov 04 2013	VCYT	VERACYTE, INC.	TREU JESSE I	Director	Option Exercise	C	0.00	680,972	0	0
Nov 04 2013	VCYT	VERACYTE, INC.	TREU JESSE I	Director	Option Exercise	C	0.00	17,677	0	0
Nov 04 2013	VCYT	VERACYTE, INC.	TREU JESSE I	Director	Option Exercise	C	0.00	2,382,322	0	0
Nov 04 2013	VCYT	VERACYTE, INC.	TREU JESSE I	Director	Buy	C	0.00	22,730	0	22,730	0 to 22.7 K
Nov 04 2013	VCYT	VERACYTE, INC.	TREU JESSE I	Director	Buy	C	0.00	3,063,294	0	3,063,294	0 to 3.1 M
Nov 19 2013	TNDM	TANDEM DIABETES CA ...	TREU JESSE I	Director	Option Exercise	J	7.37	6,008	44,279	6,008
Nov 19 2013	TNDM	TANDEM DIABETES CA ...	TREU JESSE I	Director	Option Exercise	J	4.40	10,068	44,299	0
Nov 19 2013	TNDM	TANDEM DIABETES CA ...	TREU JESSE I	Director	Option Exercise	C	0.00	38,941	0	0
Nov 19 2013	TNDM	TANDEM DIABETES CA ...	TREU JESSE I	Director	Option Exercise	C	0.00	9,378	0	0
Nov 19 2013	TNDM	TANDEM DIABETES CA ...	TREU JESSE I	Director	Option Exercise	C	0.00	6,071	0	0
Nov 19 2013	TNDM	TANDEM DIABETES CA ...	TREU JESSE I	Director	Option Exercise	J	7.37	352,351	2,596,827	352,351
Nov 19 2013	TNDM	TANDEM DIABETES CA ...	TREU JESSE I	Director	Option Exercise	J	4.40	590,403	2,597,773	0
Nov 19 2013	TNDM	TANDEM DIABETES CA ...	TREU JESSE I	Director	Option Exercise	C	0.00	2,283,114	0	0
Nov 19 2013	TNDM	TANDEM DIABETES CA ...	TREU JESSE I	Director	Option Exercise	C	0.00	549,833	0	0
Nov 19 2013	TNDM	TANDEM DIABETES CA ...	TREU JESSE I	Director	Option Exercise	C	0.00	356,111	0	0
Nov 19 2013	TNDM	TANDEM DIABETES CA ...	TREU JESSE I	Director	Buy	C	0.00	54,390	0	54,390	0 to 54.4 K
Nov 19 2013	TNDM	TANDEM DIABETES CA ...	TREU JESSE I	Director	Buy	C	0.00	3,189,058	0	3,189,058	0 to 3.2 M
Nov 15 2013	TNDM	TANDEM DIABETES CA ...	TREU JESSE I	Director	Option Exercise	A	15.00	17,000	255,000	17,000
Aug 28 2013	TBRA	Tobira Therapeutic ...	TREU JESSE I	Director	Option Exercise	A	4.00	17,964	71,856	17,964
Aug 28 2013	TBRA	Tobira Therapeutic ...	TREU JESSE I	Director	Option Exercise	C	0.00	7,407	0	0
Aug 28 2013	TBRA	Tobira Therapeutic ...	TREU JESSE I	Director	Option Exercise	C	0.00	2,899	0	0
Aug 28 2013	TBRA	Tobira Therapeutic ...	TREU JESSE I	Director	Option Exercise	C	0.00	4,233	0	0
Aug 28 2013	TBRA	Tobira Therapeutic ...	TREU JESSE I	Director	Option Exercise	C	0.00	225,913	0	0
Aug 28 2013	TBRA	Tobira Therapeutic ...	TREU JESSE I	Director	Option Exercise	C	0.00	894,120	0	0
Aug 28 2013	TBRA	Tobira Therapeutic ...	TREU JESSE I	Director	Option Exercise	C	0.00	270,568	0	0
Aug 28 2013	TBRA	Tobira Therapeutic ...	TREU JESSE I	Director	Option Exercise	C	0.00	394,969	0	0
Aug 28 2013	TBRA	Tobira Therapeutic ...	TREU JESSE I	Director	Buy	C	0.00	7,407	0	14,920	7.5 K to 14.9 K (+98.59 %)
Aug 28 2013	TBRA	Tobira Therapeutic ...	TREU JESSE I	Director	Buy	C	0.00	2,899	0	7,513	4.6 K to 7.5 K (+62.83 %)
Aug 28 2013	TBRA	Tobira Therapeutic ...	TREU JESSE I	Director	Buy	C	0.00	4,233	0	4,614	381 to 4.6 K (+1,111.02 %)
Aug 28 2013	TBRA	Tobira Therapeutic ...	TREU JESSE I	Director	Buy	P	4.00	750,000	3,000,000	2,571,117	1.8 M to 2.6 M (+41.18 %)
Aug 28 2013	TBRA	Tobira Therapeutic ...	TREU JESSE I	Director	Buy	C	0.00	225,913	0	1,821,117	1.6 M to 1.8 M (+14.16 %)
Aug 28 2013	TBRA	Tobira Therapeutic ...	TREU JESSE I	Director	Buy	C	0.00	894,120	0	1,595,204	701.1 K to 1.6 M (+127.53 %)
Aug 28 2013	TBRA	Tobira Therapeutic ...	TREU JESSE I	Director	Buy	C	0.00	270,568	0	701,084	430.5 K to 701.1 K (+62.85 %)
Aug 28 2013	TBRA	Tobira Therapeutic ...	TREU JESSE I	Director	Buy	C	0.00	394,969	0	430,516	35.5 K to 430.5 K (+1,111.12 %)
Jul 16 2013	TZYM	Ocera Therapeutics ...	TREU JESSE I	10% Owner	Buy	P	6.03	331,873	1,999,999	1,897,336	1.6 M to 1.9 M (+21.20 %)
Jul 16 2013	TZYM	Ocera Therapeutics ...	TREU JESSE I	10% Owner	Buy	P	6.03	7,333	44,192	7,333	0 to 7.3 K
Jul 16 2013	TZYM	Ocera Therapeutics ...	TREU JESSE I	10% Owner	Buy	P	6.03	988,285	5,955,801	988,285	0 to 988.3 K
Sep 30 2013	EVOK	Evoke Pharma Inc	TREU JESSE I	10% Owner	Option Exercise	C	0.00	19,006	0	0
Sep 30 2013	EVOK	Evoke Pharma Inc	TREU JESSE I	10% Owner	Option Exercise	C	0.00	1,114,327	0	0
Sep 30 2013	EVOK	Evoke Pharma Inc	TREU JESSE I	10% Owner	Buy	C	0.00	19,006	0	19,006	0 to 19 K
Sep 30 2013	EVOK	Evoke Pharma Inc	TREU JESSE I	10% Owner	Buy	C	0.00	1,114,327	0	1,114,327	0 to 1.1 M
Jul 02 2013	ESPR	Esperion Therapeut ...	TREU JESSE I	10% Owner	Option Exercise	J	6.99	1,193	8,339	1,193
Jul 02 2013	ESPR	Esperion Therapeut ...	TREU JESSE I	10% Owner	Option Exercise	J	1.00	8,346	8,346	0
Jul 02 2013	ESPR	Esperion Therapeut ...	TREU JESSE I	10% Owner	Option Exercise	C	0.00	30,462	0	0
Jul 02 2013	ESPR	Esperion Therapeut ...	TREU JESSE I	10% Owner	Option Exercise	J	6.99	70,042	489,594	70,042
Jul 02 2013	ESPR	Esperion Therapeut ...	TREU JESSE I	10% Owner	Option Exercise	J	1.00	489,320	489,320	0
Jul 02 2013	ESPR	Esperion Therapeut ...	TREU JESSE I	10% Owner	Option Exercise	C	0.00	1,786,012	0	0
Jul 02 2013	ESPR	Esperion Therapeut ...	TREU JESSE I	10% Owner	Buy	P	14.00	4,791	67,074	35,253	30.5 K to 35.3 K (+15.73 %)
Jul 02 2013	ESPR	Esperion Therapeut ...	TREU JESSE I	10% Owner	Buy	C	0.00	30,462	0	30,462	0 to 30.5 K
Jul 02 2013	ESPR	Esperion Therapeut ...	TREU JESSE I	10% Owner	Buy	P	14.00	280,923	3,932,922	2,066,935	1.8 M to 2.1 M (+15.73 %)
Jul 02 2013	ESPR	Esperion Therapeut ...	TREU JESSE I	10% Owner	Buy	C	0.00	1,786,012	0	1,786,012	0 to 1.8 M
Jan 18 2013	ACHN	ACHILLION PHARMACE ...	TREU JESSE I	10% Owner	Buy	J	0.00	66,462	0	159,896	93.4 K to 159.9 K (+71.13 %)
Jan 18 2013	ACHN	ACHILLION PHARMACE ...	TREU JESSE I	10% Owner	Sell	J	0.00	1,000,000	0	5,772,968	6.8 M to 5.8 M (-14.76 %)
Jul 24 2012	DRTX	Durata Therapeutic ...	TREU JESSE I	10% Owner	Option Exercise	C	0.00	16,529	0	0
Jul 24 2012	DRTX	Durata Therapeutic ...	TREU JESSE I	10% Owner	Option Exercise	C	0.00	2,227,596	0	0
Jul 24 2012	DRTX	Durata Therapeutic ...	TREU JESSE I	10% Owner	Buy	P	9.00	5,777	51,993	22,306	16.5 K to 22.3 K (+34.95 %)
Jul 24 2012	DRTX	Durata Therapeutic ...	TREU JESSE I	10% Owner	Buy	C	0.00	16,529	0	16,529	0 to 16.5 K
Jul 24 2012	DRTX	Durata Therapeutic ...	TREU JESSE I	10% Owner	Buy	P	9.00	778,536	7,006,824	3,006,132	2.2 M to 3 M (+34.95 %)
Jul 24 2012	DRTX	Durata Therapeutic ...	TREU JESSE I	10% Owner	Buy	C	0.00	2,227,596	0	2,227,596	0 to 2.2 M
Jun 04 2012	ACHN	ACHILLION PHARMACE ...	TREU JESSE I	10% Owner	Buy	J	0.00	93,434	0	93,434	0 to 93.4 K
Jun 04 2012	ACHN	ACHILLION PHARMACE ...	TREU JESSE I	10% Owner	Sell	J	0.00	1,200,000	0	6,772,968	8 M to 6.8 M (-15.05 %)
Mar 27 2012	RVA	REVA Medical, Inc.	TREU JESSE I	10% Owner	Sell	S	5.16	39,136	201,942	85,186	124.3 K to 85.2 K (-31.48 %)
Mar 27 2012	RVA	REVA Medical, Inc.	TREU JESSE I	10% Owner	Sell	S	5.16	1,656,581	8,547,958	3,606,002	5.3 M to 3.6 M (-31.48 %)
Dec 22 2011	OREX	Orexigen Therapeut ...	TREU JESSE I	10% Owner	Option Exercise	P	0.00	7,882	8	7,882
Dec 22 2011	OREX	Orexigen Therapeut ...	TREU JESSE I	10% Owner	Option Exercise	P	0.00	461,265	461	461,265
Dec 22 2011	OREX	Orexigen Therapeut ...	TREU JESSE I	10% Owner	Buy	P	1.45	7,882	11,429	50,643	42.8 K to 50.6 K (+18.43 %)
Dec 22 2011	OREX	Orexigen Therapeut ...	TREU JESSE I	10% Owner	Buy	P	1.45	461,265	668,834	2,967,415	2.5 M to 3 M (+18.41 %)
Nov 21 2011	CLVS	Clovis Oncology, I ...	TREU JESSE I	10% Owner	Option Exercise	C	0.00	43,809	0	0
Nov 21 2011	CLVS	Clovis Oncology, I ...	TREU JESSE I	10% Owner	Option Exercise	C	0.00	20,240	0	0
Nov 21 2011	CLVS	Clovis Oncology, I ...	TREU JESSE I	10% Owner	Option Exercise	C	0.00	20,240	0	0
Nov 21 2011	CLVS	Clovis Oncology, I ...	TREU JESSE I	10% Owner	Option Exercise	C	0.00	2,568,521	0	0
Nov 21 2011	CLVS	Clovis Oncology, I ...	TREU JESSE I	10% Owner	Option Exercise	C	0.00	1,186,657	0	0
Nov 21 2011	CLVS	Clovis Oncology, I ...	TREU JESSE I	10% Owner	Option Exercise	C	0.00	1,186,657	0	0
Nov 21 2011	CLVS	Clovis Oncology, I ...	TREU JESSE I	10% Owner	Buy	P	13.00	15,625	203,125	51,013	35.4 K to 51 K (+44.15 %)
Nov 21 2011	CLVS	Clovis Oncology, I ...	TREU JESSE I	10% Owner	Buy	C	0.00	6,324	0	35,388	29.1 K to 35.4 K (+21.76 %)
Nov 21 2011	CLVS	Clovis Oncology, I ...	TREU JESSE I	10% Owner	Buy	C	0.00	15,106	0	29,064	14 K to 29.1 K (+108.22 %)
Nov 21 2011	CLVS	Clovis Oncology, I ...	TREU JESSE I	10% Owner	Buy	C	0.00	6,979	0	13,958	7 K to 14 K (+100.00 %)
Nov 21 2011	CLVS	Clovis Oncology, I ...	TREU JESSE I	10% Owner	Buy	C	0.00	6,979	0	6,979	0 to 7 K
Nov 21 2011	CLVS	Clovis Oncology, I ...	TREU JESSE I	10% Owner	Buy	P	13.00	916,058	11,908,754	2,990,937	2.1 M to 3 M (+44.15 %)
Nov 21 2011	CLVS	Clovis Oncology, I ...	TREU JESSE I	10% Owner	Buy	C	0.00	370,799	0	2,074,879	1.7 M to 2.1 M (+21.76 %)
Nov 21 2011	CLVS	Clovis Oncology, I ...	TREU JESSE I	10% Owner	Buy	C	0.00	885,696	0	1,704,080	818.4 K to 1.7 M (+108.22 %)
Nov 21 2011	CLVS	Clovis Oncology, I ...	TREU JESSE I	10% Owner	Buy	C	0.00	409,192	0	818,384	409.2 K to 818.4 K (+100.00 %)
Nov 21 2011	CLVS	Clovis Oncology, I ...	TREU JESSE I	10% Owner	Buy	C	0.00	409,192	0	409,192	0 to 409.2 K
Sep 20 2011	ZGNX	ZOGENIX, INC.	TREU JESSE I	10% Owner	Buy	P	2.00	58,696	117,392	169,251	110.6 K to 169.3 K (+53.09 %)
Sep 20 2011	ZGNX	ZOGENIX, INC.	TREU JESSE I	10% Owner	Buy	P	2.00	3,441,304	6,882,608	9,923,335	6.5 M to 9.9 M (+53.09 %)
Jun 03 2011	ALIM	ALIMERA SCIENCES I ...	TREU JESSE I	10% Owner	Sell	S	8.04	6,914	55,589	40,790	47.7 K to 40.8 K (-14.49 %)
Jun 03 2011	ALIM	ALIMERA SCIENCES I ...	TREU JESSE I	10% Owner	Buy	J	0.00	18,864	0	18,864	0 to 18.9 K

Page: 1 2 3 4 4 next >